Stent thrombosis is a fatal complication that can cause sudden cardiac death in patients implanted coronary stent. Also, pulmonary thromboembolism is associated with increased mortality. Usually, these vascular thromboembolic diseases did not occured simultaneously. If this circumstance develops, possible mechanisms and causes should be described. Here, we report a case of patient underwent percutaneous coronary intervention under diagnosis of ST-segment elevation myocardial infarction with recurrent stent thrombosis and pulmonary thromboembolism associated with hyperhomocysteinemia despite optimal medical therapy.
INTRODUCTION
Coronary stenting is an effective management in patient with acute myocardial infarction (AMI) with coronary stenosis or obstruction. However, stent thrombosis (ST) that can be developed after stenting is a fatal complication with higher mortality rates despite relative lower incidence. 1 Also, pulmonary thromboembolism (PTE) is associated with increased mortality rates. 2 These two vascular thromboembolic diseases usually did not occured simultaneously and have different pathophysiology, etiology, risk factors and management.
Here, we report a case of patient underwent percutaneous coronary intervention (PCI) under diagnosis of ST-segment elevation myocardial infarction with recurrent ST and PTE despite optimal medical therapy. Patient experienced all types of ST and concomitant PTE during follow up period. However, precipitating factors of these events were not detected except for hyperhomocysteinemia. We discussed the possible causes of recurrent ST with PTE and further therapeutic plans in these patients.
CASE REPORT
A 75-year-old male developed sudden chest pain 3 hours ago. Pain lasted during 1 hour and he suddenly collapsed. He was rushed unconscious to a neighborhood hospital by emergency medical services. And then he transferred to our hospital for further evaluation. He was a current smoker at 70 Pack-Years and no other www.lipid.or.kr stent. We carried out direct stenting using bare-metal stent (Coroflex-Blue 3.5x19 mm, B. Braun Systems) (Fig. 3A to 3D). Despite of successful PCI, patient complained chest pain immediately after PCI. 12-lead ECG during development of pain showed STE in II, III, and aVF with complete atrioventricular block. Emergent CAG showed critical spasm over RCA and stent thrombosis (Fig. 4A) . After nitrate and abciximab infusion, distal flow was improved (Fig. 4B) . He did not have trouble with medication compliance and no chest pain was developed in other day except for the secondary admission day.
After discharge with other event, he revisited our hospital 5 months later. However, CAG at that time showed no in-stent restenosis, thrombosis and de novo lesions ( Fig. 5A and 5B). He was discharge and followed up at outpatient department without angina. At 9 months after last admission, he revisited our emergency department with comatose mental status and hypotension.
12-lead ECG showed ST-segment elevation in II, III, and aVF with complete atrioventricular block. Emergent CAG revealed recurrent ST in proximal RCA (Fig. 6A ) and we performed successful PCI with ballooning and final CAG Although he ceased warfarin ealier compared with recommended medication periods, other medication compliance was good (Fig. 7) .
DISCUSSION
In interventional cardiology era, especially with coronary stenting, ST is a dreadful complication of PCI. It causes AMI or sudden cardiac death in the most cases despite its low incidence of 0.5% to 2.0% in bare metal stent (BMS). 3 BMS implantation, rapid re-endothelization occurs within a few weeks after procedure contrary to drug-eluting stent (DES). Although recent several studies showed similar frequencies of ST episodes between DES and BMS, incidence of very late stent thrombosis (VLST)
is still higher in DES than BMS. 4 There are little studies or case report considering BMS ST, but a few case reports showed VLST in BMS or recurrent VLST in BMS. 5 However, development of ST concomitant with PTE is very rare. 
